Histocompatible platelet transfusion for patients with leukemia

C. A. Schiffer, J. P. Dutcher, D. E. Hogge, Joseph Aisner

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Alloimmunization represents the major complication of platelet transfusion therapy. In the late 1960s it was first reported that platelets from both family members and nonrelated donors matched at the HLA A and B loci could circulate normally in some recipients who were otherwise refractory to platelet transfusions from nonmatched donors. Since that time, large pools of HLA-typed donors have been developed in many centers to help provide platelet transfusion support for such alloimmunized patients. It has recently been recognized that a significant percentage of either fully or partially HLA-matched transfusions are ineffective. Because of the considerable expense and effort required for donor recruitment, platelet collection, HLA typing, and computer utilization, it is important to refine donor selection further by HLA typing, and possibly to supplement HLA typing with other cross-matching techniques.

Original languageEnglish (US)
Pages (from-to)273-281
Number of pages9
JournalPlasma Therapy and Transfusion Technology
Issue number3
StatePublished - 1982

All Science Journal Classification (ASJC) codes

  • Immunology
  • Hematology

Fingerprint Dive into the research topics of 'Histocompatible platelet transfusion for patients with leukemia'. Together they form a unique fingerprint.

Cite this